Innoviva, Inc. (INVA) stock
INVANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 14/3040% below fair value
$19.03+0.06 (+0.32%)
Close on Nov 13, 2026Market cap $1.37BP/E 9.7Yield –
Innoviva enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Innoviva's enterprise value was $1.06B on Nov 11, 2026, against $1.41B a year earlier. Over the last 5 years it ranged from $1.03B to $1.65B, with a median of $1.28B.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $1.06B | -17.1% |
| 2025 | Dec 31, 2025 | $1.28B | +0.2% |
| 2024 | Dec 31, 2024 | $1.27B | -1.9% |
| 2023 | Dec 29, 2023 | $1.30B | +11.6% |
| 2022 | Dec 30, 2022 | $1.16B | -24.7% |
| 2021 | Dec 31, 2021 | $1.54B | +27.7% |
| 2020 | Dec 31, 2020 | $1.21B | -21.6% |
| 2019 | Dec 31, 2019 | $1.54B | -33.9% |
| 2018 | Dec 31, 2018 | $2.33B | +3.7% |
| 2017 | Dec 29, 2017 | $2.25B | +22.3% |
| 2016 | Dec 30, 2016 | $1.84B | +5.2% |
| 2015 | Dec 31, 2015 | $1.75B | -12.8% |
| 2014 | Dec 31, 2014 | $2.01B | -41.5% |
| 2013 | Dec 31, 2013 | $3.43B | +80.5% |
| 2012 | Dec 31, 2012 | $1.90B | +43.3% |
| 2011 | Dec 30, 2011 | $1.33B | -13.4% |
| 2010 | Dec 31, 2010 | $1.53B | – |
See a number that looks wrong?